The Src Inhibitor AZD0530 Reversibly Inhibits the Formation and Activity of Human Osteoclasts (original) (raw)
Related papers
Decreased C-Src Expression Enhances Osteoblast Differentiation and Bone Formation
Journal of Cell Biology, 2000
Osteogenic Effects of a Potent Src-over-Abl-Selective Kinase Inhibitor in the Mouse
Journal of Pharmacology and Experimental Therapeutics, 2011
Osteoclastogenesis - Current knowledge and future perspectives
Journal of musculoskeletal & neuronal interactions
The Src family kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivo
Proceedings of the National Academy of Sciences of the United States of America, 2009
Mehdi Najar, Laurence Lagneaux
BMC Cancer, 2010
AZT Enhances Osteoclastogenesis and Bone Loss
AIDS Research and Human Retroviruses, 2004
Src-like adaptor protein regulates osteoclast generation and survival
Journal of Cellular Biochemistry, 2010
Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts
Journal of Bone and Mineral Research, 2013
Regulation of Osteoclast Formation and Function
Reviews in Endocrine & Metabolic Disorders, 2001
Src Inhibitors in Metastatic Bone Disease
Clinical Cancer Research, 2006
Journal of Clinical Investigation, 1998
Journal of Biomedical Materials Research, 2004
Bone, 2009
Oncogene, 2010
Smac-mimetics reduce numbers and viability of human osteoclasts
Cell Death Discovery, 2021
Current Medicinal Chemistry, 2011
Inhibitors of histone deacetylases in class I and class II suppress human osteoclasts in vitro
Journal of Cellular Physiology, 2011
Effects of a checkpoint kinase inhibitor, AZD7762, on tumor suppression and bone remodeling
International journal of oncology, 2018
Mechanisms of spontaneous osteoclastogenesis in cancer with bone involvement
The FASEB Journal, 2004
Journal of Bone Oncology, 2019
Osteoclasts Direct Bystander Killing of Bone Cancer
Cancer Research, 2006
Inhibition of Protein Kinase c-Src as a Therapeutic Approach for Cancer and Bone Metastases
Anti-Cancer Agents in Medicinal Chemistry
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions
Oncotarget, 2017
Src kinase activity is essential for osteoclast function
Journal of Biological …, 2004
A novel osteoblast-derived molecule that inhibits the early phase of osteoclast formation
Bone, 2000
Journal of Cellular Biochemistry, 2011
Cancer and bone disease (ASBMR 2013)
IBMS BoneKEy, 2014
Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530
Molecular Oncology, 2009